Lauren Herrera and Chantelle Loehner have been banned from competition as a result of their breach of the CrossFit Drug Testing Policy, reports “games.crossfit.com”.
Herrera tested positive for andarine, a metabolite of LGD4033 and metabolites of GW1516 on the 12th of April 2019, at the Mid-Atlantic CrossFit Challenge. Herrera is suspended for four years and will not be eligible to compete again until the 12th of April 2023.
Loehner also tested positive for metabolites of Oral Turinabol on the 14th of April 2019.
But for real.. I don’t care how much you lift or how fast you can move and idc if you can do it all at 100lbs. If you obtain this shit because you’re doping, You. Are. Not. Impressive. 😂🙄 like bye 👋🏽
— Rachel Kenney (@_raychkay) June 7, 2019
Invictus X finished first overall at the Mid-Atlantic CrossFit Challenge, but the invitation to the CrossFit Games was withheld and no Games team roster was submitted, pending the completion of the appeals process for this case.
Team members in compliance with the Drug Policy are eligible to compete in future competitions.
Loehner’s appeals process is now complete and she is suspended for four years. She will not be eligible until the 14th of April 2023.
Loehner’s placement in the top 20 in the Open has been invalidated. The qualifying spot will pass to the next eligible athlete!